Medical Development Group (MDG)

Great science matters. But in MedTech, the wrong assumptions can get expensive fast.

Are you solving the right problem?
Telling investors the right story?
Mistaking interest for traction?
Planning for approval—but not adoption?

Join Katherine King French, MBA and Bill Schick, MBA for an MDG Boston Lunch & Learn Masterclass exploring seven costly mistakes that can derail a raise, pilot, launch, or next stage of growth.

This is a hands-on session—you’ll pressure-test your assumptions and leave with a focused 30-day action plan.

If you’re building, funding, advising, or commercializing in MedTech or life sciences, this is one to put on the calendar.

Bring your assumptions. We’ll help you find the expensive ones. 🎯

Eventbrite for tickets: https://www.eventbrite.com/e/why-great-science-still-fails-how-to-avoid-7-costly-mistakes-in-medtech-tickets-1997982670953?aff=ebemoffollowpublishemail&ref=eemail&utm_campaign=following_published_event&utm_content=follow_notification&utm_medium=email&utm_source=eventbrite

Michael has served for over a decade as an Operating Partner at Riverside Partners, a healthcare private equity investment firm. He will share his 30+ year journey from engineer / scientist to medical device CEO through multiple sale transactions to private equity healthcare investor, highlighting Riverside’s investment mandate and the evolution of his book, “Dancing Between the Toes of Elephants” that achieved Amazon #1 Best Seller in PE, VC, and Career Development categories. The book was also featured by the Boston Business Journal as one of the most “Notable Business Books of 2025”.

Link to tickets here: https://www.eventbrite.com/e/innovation-leadership-from-engineer-to-med-device-ceo-to-investor-tickets-1994714881908?aff=oddtdtcreator